Alembic Pharmaceuticals Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 1,891.81 | 1,917.06 | 1,717.22 | 1,783.83 | 1,702.24 |
| Other Income Qtr Cr | 15.50 | 6.91 | 6.50 | 14.19 | 9.50 |
| Operating Revenues Qtr | 1,876.31 | 1,910.15 | 1,710.72 | 1,769.64 | 1,692.74 |
Loading chart... | |||||
Operating Expenses Qtr | 1,582.82 | 1,594.46 | 1,429.37 | 1,497.71 | 1,432.52 |
Operating Profit Qtr | 293.49 | 315.69 | 281.35 | 271.93 | 260.22 |
EBITDA Qtr Cr | 266.76 | 322.60 | 287.85 | 286.12 | 269.72 |
Depreciation Qtr | 80.12 | 76.07 | 73.77 | 68.99 | 70.04 |
Net Profit Qtr | 132.97 | 184.71 | 154.38 | 156.89 | 138.42 |
Basic EPS Qtr | 6.76 | 9.40 | 7.85 | 7.98 | 7.01 |
Open Demat Account